Predictions
Lava Therapeutics B.v.
Start price
Target price
Perf. (%)
€1.97
19.02.24
19.02.24
€10.00
19.02.25
19.02.25
44.16%
10.05.24
10.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.40
19.02.24
19.02.24
€85.00
30.09.25
30.09.25
-11.38%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
poLight ASA
Start price
Target price
Perf. (%)
€1.06
19.02.24
19.02.24
-
19.02.25
19.02.25
-80.83%
09.05.24
09.05.24
Probably not worthwhile Investment
Little innovation
Trupanion Inc.
Start price
Target price
Perf. (%)
€21.20
19.02.24
19.02.24
-
19.02.25
19.02.25
8.25%
09.05.24
09.05.24
Risky Investment
Theravet S.a.
Start price
Target price
Perf. (%)
€1.04
19.02.24
19.02.24
-
19.02.25
19.02.25
-36.35%
09.05.24
09.05.24
Probably not worthwhile Investment
Little innovation
2CRSI S.A.
Start price
Target price
Perf. (%)
€5.14
19.02.24
19.02.24
-
19.02.25
19.02.25
-17.22%
09.05.24
09.05.24
Could be worthwhile Investment >10% per year
Deutsche Telekom AG
Start price
Target price
Perf. (%)
€22.27
19.02.24
19.02.24
€23.30
19.02.25
19.02.25
2.11%
10.05.24
10.05.24
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.45
19.02.24
19.02.24
€0.000
19.02.25
19.02.25
-64.60%
10.05.24
10.05.24
Fibrogen Inc.
Start price
Target price
Perf. (%)
€2.14
19.02.24
19.02.24
€6.00
31.07.27
31.07.27
-51.85%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
Unipol Gruppo Finanziario SpA
Start price
Target price
Perf. (%)
€6.76
19.02.24
19.02.24
-
19.02.25
19.02.25
27.07%
10.05.24
10.05.24
Risky Investment
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€12.05
18.02.24
18.02.24
€13.50
08.06.24
08.06.24
25.31%
10.05.24
10.05.24
CrowdStrike Holdings Inc
Start price
Target price
Perf. (%)
€306.05
18.02.24
18.02.24
€300.00
18.02.25
18.02.25
-2.71%
10.05.24
10.05.24
LiveRamp Holdings, Inc.
Start price
Target price
Perf. (%)
€33.80
18.02.24
18.02.24
-
18.02.25
18.02.25
-11.83%
09.05.24
09.05.24
China Sxt Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.98
18.02.24
18.02.24
-
18.02.25
18.02.25
-49.85%
10.05.24
10.05.24
High valuation
Bad rating
Lower EBIT Margin than peer group
Low dividend yield expected
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.10
18.02.24
18.02.24
-
18.02.25
18.02.25
-40.08%
09.05.24
09.05.24
Probably not worthwhile Investment
Bad rating
High valuation
Low dividend yield expected